Annual Short Term Debt
$2.23 B
-$1.05 B-32.12%
December 1, 2024
Summary
- As of February 26, 2025, BMY annual short term debt is $2.23 billion, with the most recent change of -$1.05 billion (-32.12%) on December 1, 2024.
- During the last 3 years, BMY annual short term debt has fallen by -$2.89 billion (-56.48%).
- BMY annual short term debt is now -56.48% below its all-time high of $5.12 billion, reached on December 31, 2021.
Performance
BMY Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$2.23 B
+$984.00 M+79.16%
December 1, 2024
Summary
- As of February 26, 2025, BMY quarterly short term debt is $2.23 billion, with the most recent change of +$984.00 million (+79.16%) on December 1, 2024.
- Over the past year, BMY quarterly short term debt has dropped by -$1.05 billion (-32.12%).
- BMY quarterly short term debt is now -71.05% below its all-time high of $7.69 billion, reached on March 31, 2022.
Performance
BMY Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
BMY Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.1% | -32.1% |
| 3 y3 years | -56.5% | -32.1% |
| 5 y5 years | -36.0% | -32.1% |
BMY Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.5% | at low | -71.0% | +79.2% |
| 5 y | 5-year | -56.5% | at low | -71.0% | +79.2% |
| alltime | all time | -56.5% | +1836.5% | -71.0% | +2000.9% |
Bristol-Myers Squibb Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.23 B(-32.1%) | $2.23 B(+79.2%) |
| Sep 2024 | - | $1.24 B(-66.5%) |
| Jun 2024 | - | $3.71 B(-41.7%) |
| Mar 2024 | - | $6.36 B(+93.8%) |
| Dec 2023 | $3.28 B(-25.4%) | $3.28 B(-41.6%) |
| Sep 2023 | - | $5.62 B(+76.2%) |
| Jun 2023 | - | $3.19 B(+9.1%) |
| Mar 2023 | - | $2.92 B(-33.6%) |
| Dec 2022 | $4.40 B(-14.0%) | $4.40 B(+91.4%) |
| Sep 2022 | - | $2.30 B(-55.1%) |
| Jun 2022 | - | $5.12 B(-33.4%) |
| Mar 2022 | - | $7.69 B(+50.3%) |
| Dec 2021 | $5.12 B(+104.4%) | $5.12 B(-2.3%) |
| Sep 2021 | - | $5.24 B(+85.2%) |
| Jun 2021 | - | $2.83 B(+46.0%) |
| Mar 2021 | - | $1.94 B(-22.6%) |
| Dec 2020 | $2.50 B(-28.0%) | $2.50 B(-32.7%) |
| Sep 2020 | - | $3.72 B(-24.9%) |
| Jun 2020 | - | $4.95 B(+23.9%) |
| Mar 2020 | - | $4.00 B(+14.9%) |
| Dec 2019 | $3.48 B(+104.3%) | $3.48 B(+447.9%) |
| Sep 2019 | - | $635.00 M(+3.8%) |
| Jun 2019 | - | $612.00 M(+45.4%) |
| Mar 2019 | - | $421.00 M(-75.3%) |
| Dec 2018 | $1.70 B(+72.5%) | $1.70 B(+5.1%) |
| Sep 2018 | - | $1.62 B(-5.6%) |
| Jun 2018 | - | $1.72 B(-10.9%) |
| Mar 2018 | - | $1.93 B(+95.0%) |
| Dec 2017 | $987.00 M(-0.5%) | $987.00 M(-32.4%) |
| Sep 2017 | - | $1.46 B(+11.9%) |
| Jun 2017 | - | $1.31 B(+9.1%) |
| Mar 2017 | - | $1.20 B(+20.7%) |
| Dec 2016 | $992.00 M(+613.7%) | $992.00 M(+0.2%) |
| Sep 2016 | - | $990.00 M(+538.7%) |
| Jun 2016 | - | $155.00 M(+46.2%) |
| Mar 2016 | - | $106.00 M(-23.7%) |
| Dec 2015 | $139.00 M(-76.4%) | $139.00 M(-78.3%) |
| Sep 2015 | - | $642.00 M(-15.0%) |
| Jun 2015 | - | $755.00 M(+128.8%) |
| Mar 2015 | - | $330.00 M(-44.1%) |
| Dec 2014 | $590.00 M(+64.3%) | $590.00 M(+47.1%) |
| Sep 2014 | - | $401.00 M(+9.9%) |
| Jun 2014 | - | $365.00 M(+29.9%) |
| Mar 2014 | - | $281.00 M(-21.7%) |
| Dec 2013 | $359.00 M(-56.5%) | $359.00 M(-47.2%) |
| Sep 2013 | - | $680.00 M(-11.0%) |
| Jun 2013 | - | $764.00 M(-44.3%) |
| Mar 2013 | - | $1.37 B(+66.1%) |
| Dec 2012 | $826.00 M(+618.3%) | $826.00 M(+10.0%) |
| Sep 2012 | - | $751.00 M(+218.2%) |
| Jun 2012 | - | $236.00 M(+62.8%) |
| Mar 2012 | - | $145.00 M(+26.1%) |
| Dec 2011 | $115.00 M(-1.7%) | $115.00 M(-36.8%) |
| Sep 2011 | - | $182.00 M(-2.7%) |
| Jun 2011 | - | $187.00 M(+38.5%) |
| Mar 2011 | - | $135.00 M(+15.4%) |
| Dec 2010 | $117.00 M(-49.4%) | $117.00 M(-59.7%) |
| Jun 2010 | - | $290.00 M(+39.4%) |
| Mar 2010 | - | $208.00 M(-10.0%) |
| Dec 2009 | $231.00 M(+50.0%) | $231.00 M(-19.2%) |
| Sep 2009 | - | $286.00 M(+130.6%) |
| Jun 2009 | - | $124.00 M(-20.5%) |
| Mar 2009 | - | $156.00 M(+1.3%) |
| Dec 2008 | $154.00 M(-91.9%) | $154.00 M(+14.1%) |
| Sep 2008 | - | $135.00 M(-92.5%) |
| Jun 2008 | - | $1.80 B(+1.0%) |
| Mar 2008 | - | $1.78 B(-5.8%) |
| Dec 2007 | $1.89 B | $1.89 B(+0.6%) |
| Sep 2007 | - | $1.88 B(+634.0%) |
| Jun 2007 | - | $256.00 M(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2007 | - | $241.00 M(+28.9%) |
| Dec 2006 | $187.00 M(-19.0%) | $187.00 M(-70.3%) |
| Sep 2006 | - | $630.00 M(+233.3%) |
| Jun 2006 | - | $189.00 M(-19.2%) |
| Mar 2006 | - | $234.00 M(+1.3%) |
| Dec 2005 | $231.00 M(-87.7%) | $231.00 M(-16.6%) |
| Sep 2005 | - | $277.00 M(-5.1%) |
| Jun 2005 | - | $292.00 M(+19.7%) |
| Mar 2005 | - | $244.00 M(-87.0%) |
| Dec 2004 | $1.88 B(+711.6%) | $1.88 B(+14.1%) |
| Sep 2004 | - | $1.65 B(+63.5%) |
| Jun 2004 | - | $1.01 B(+30.0%) |
| Mar 2004 | - | $776.00 M(+234.5%) |
| Dec 2003 | $232.00 M(-83.2%) | $232.00 M(-82.0%) |
| Sep 2003 | - | $1.29 B(-32.3%) |
| Jun 2003 | - | $1.90 B(-15.4%) |
| Mar 2003 | - | $2.25 B(+62.9%) |
| Dec 2002 | $1.38 B(+692.5%) | $1.38 B(+72.6%) |
| Sep 2002 | - | $799.00 M(+1.8%) |
| Jun 2002 | - | $785.00 M(+154.9%) |
| Mar 2002 | - | $308.00 M(+77.0%) |
| Dec 2001 | $174.00 M(+7.4%) | $174.00 M(-90.0%) |
| Sep 2001 | - | $1.73 B(+970.4%) |
| Jun 2001 | - | $162.00 M(-10.5%) |
| Mar 2001 | - | $181.00 M(+11.7%) |
| Dec 2000 | $162.00 M(-62.5%) | $162.00 M(-6.4%) |
| Sep 2000 | - | $173.00 M(-32.9%) |
| Jun 2000 | - | $258.00 M(-29.3%) |
| Mar 2000 | - | $365.00 M(-15.5%) |
| Dec 1999 | $432.00 M(-10.4%) | $432.00 M(-15.6%) |
| Sep 1999 | - | $512.00 M(-6.2%) |
| Jun 1999 | - | $546.00 M(+2.1%) |
| Mar 1999 | - | $535.00 M(+11.0%) |
| Dec 1998 | $482.00 M(-11.2%) | $482.00 M(-4.4%) |
| Sep 1998 | - | $504.00 M(+11.3%) |
| Jun 1998 | - | $453.00 M(-16.4%) |
| Mar 1998 | - | $542.00 M(-0.2%) |
| Dec 1997 | $543.00 M(+5.8%) | $543.00 M(+0.6%) |
| Sep 1997 | - | $540.00 M(-13.2%) |
| Jun 1997 | - | $622.00 M(+5.2%) |
| Mar 1997 | - | $591.00 M(+15.2%) |
| Dec 1996 | $513.00 M(-10.8%) | $513.00 M(-3.2%) |
| Sep 1996 | - | $530.00 M(+6.9%) |
| Jun 1996 | - | $496.00 M(-5.7%) |
| Mar 1996 | - | $526.00 M(-8.5%) |
| Dec 1995 | $575.00 M(-20.7%) | $575.00 M(-17.7%) |
| Sep 1995 | - | $699.00 M(-16.0%) |
| Jun 1995 | - | $832.00 M(+4.5%) |
| Mar 1995 | - | $796.00 M(+9.8%) |
| Dec 1994 | $725.00 M(+309.6%) | $725.00 M(-4.0%) |
| Sep 1994 | - | $755.00 M(+241.6%) |
| Jun 1994 | - | $221.00 M(+5.2%) |
| Mar 1994 | - | $210.00 M(+18.6%) |
| Dec 1993 | $177.00 M(-52.8%) | $177.00 M(-31.1%) |
| Jun 1993 | - | $257.00 M(-17.4%) |
| Mar 1993 | - | $311.00 M(-17.1%) |
| Dec 1992 | $375.00 M(-32.2%) | $375.00 M(-7.9%) |
| Sep 1992 | - | $407.00 M(-8.5%) |
| Jun 1992 | - | $445.00 M(-0.9%) |
| Mar 1992 | - | $449.00 M(-18.8%) |
| Dec 1991 | $553.00 M(+39.3%) | $553.00 M(+24.5%) |
| Sep 1991 | - | $444.00 M(+9.9%) |
| Jun 1991 | - | $404.00 M(+22.1%) |
| Mar 1991 | - | $331.00 M(-16.6%) |
| Dec 1990 | $397.00 M(+41.3%) | $397.00 M(+23.3%) |
| Sep 1990 | - | $322.00 M(-0.3%) |
| Jun 1990 | - | $323.00 M(+14.5%) |
| Mar 1990 | - | $282.00 M(+0.4%) |
| Dec 1989 | $281.00 M(-58.6%) | $281.00 M(-58.6%) |
| Dec 1988 | $679.00 M(+63.6%) | $679.00 M(+63.6%) |
| Dec 1987 | $415.00 M | $415.00 M |
FAQ
- What is Bristol-Myers Squibb annual short term debt?
- What is the all time high annual short term debt for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual short term debt year-on-year change?
- What is Bristol-Myers Squibb quarterly short term debt?
- What is the all time high quarterly short term debt for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly short term debt year-on-year change?
What is Bristol-Myers Squibb annual short term debt?
The current annual short term debt of BMY is $2.23 B
What is the all time high annual short term debt for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual short term debt is $5.12 B
What is Bristol-Myers Squibb annual short term debt year-on-year change?
Over the past year, BMY annual short term debt has changed by -$1.05 B (-32.12%)
What is Bristol-Myers Squibb quarterly short term debt?
The current quarterly short term debt of BMY is $2.23 B
What is the all time high quarterly short term debt for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly short term debt is $7.69 B
What is Bristol-Myers Squibb quarterly short term debt year-on-year change?
Over the past year, BMY quarterly short term debt has changed by -$1.05 B (-32.12%)